Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Name / Ticker | Price | Zen Rating |
---|---|---|
$13.87 | A | |
$34.98 | A | |
$7.75 | A |